Name | Bcp Blue Hill, Llc |
---|---|
Location | 414 North Willson, Blue Hill, Nebraska |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 62 |
Occupancy Rate | 50.16% |
Medicare ID (CCN) | 285144 |
Legal Business Name | Bcp Blue Hill Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1558317024 |
Organization Name | FIVE STAR QUALITY CARE-NE LLC |
Doing Business As | BLUE HILL CARE CENTER |
Address | 414 N Willson St, Blue Hill, NE 68930 |
Phone Number | 402-756-2080 |
News Archive
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.
› Verified 5 days ago
NPI Number | 1710668421 |
Organization Name | PINES AT BLUE HILL LLC |
Address | 414 N Willson St, Blue Hill, NE 68930 |
Phone Number | 402-756-2080 |
News Archive
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.
› Verified 5 days ago
NPI Number | 1851952758 |
Organization Name | BCP BLUE HILL, LLC |
Address | 414 N Willson St, Blue Hill, NE 68930 |
Phone Number | 402-756-2080 |
News Archive
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $13000 |
Number of Payment Denials | 1 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 21.15 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.15 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 8.77 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.63 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.45 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.77 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 32.77 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 86.75 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.04 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.02 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 5.71 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.5 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 88.24 | 95.98 |
Percentage of short-stay residents who made improvements in function | 79.55 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 86.25 | 82.93 |
News Archive
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.
› Verified 5 days ago